- Home
- CXH vs YI Comparison
CXH vs YI Comparison
Compare CXH & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXH
- YI
- Stock Information
- Founded
- CXH 1989
- YI 2010
- Country
- CXH United States
- YI China
- Employees
- CXH N/A
- YI N/A
- Industry
- CXH Investment Managers
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- CXH Finance
- YI Consumer Staples
- Exchange
- CXH Nasdaq
- YI Nasdaq
- Market Cap
- CXH 62.5M
- YI 60.7M
- IPO Year
- CXH N/A
- YI N/A
- Fundamental
- Price
- CXH $7.47
- YI $6.98
- Analyst Decision
- CXH
- YI
- Analyst Count
- CXH 0
- YI 0
- Target Price
- CXH N/A
- YI N/A
- AVG Volume (30 Days)
- CXH 25.9K
- YI 13.1K
- Earning Date
- CXH 01-01-0001
- YI 09-02-2025
- Dividend Yield
- CXH 3.56%
- YI N/A
- EPS Growth
- CXH N/A
- YI N/A
- EPS
- CXH 0.23
- YI N/A
- Revenue
- CXH N/A
- YI $1,984,717,013.00
- Revenue This Year
- CXH N/A
- YI N/A
- Revenue Next Year
- CXH N/A
- YI N/A
- P/E Ratio
- CXH $33.35
- YI N/A
- Revenue Growth
- CXH N/A
- YI N/A
- 52 Week Low
- CXH $6.41
- YI $4.15
- 52 Week High
- CXH $7.74
- YI $11.90
- Technical
- Relative Strength Index (RSI)
- CXH 46.01
- YI 48.24
- Support Level
- CXH $7.43
- YI $6.44
- Resistance Level
- CXH $7.55
- YI $7.47
- Average True Range (ATR)
- CXH 0.04
- YI 0.29
- MACD
- CXH -0.00
- YI 0.07
- Stochastic Oscillator
- CXH 26.92
- YI 60.08
About CXH MFS Investment Grade Municipal Trust
Mfs Investment Grade Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowing for investment purposes, in tax-exempt bonds and tax-exempt notes.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.